5.53
price down icon5.15%   -0.30
after-market Dopo l'orario di chiusura: 5.60 0.07 +1.27%
loading
Precedente Chiudi:
$5.83
Aprire:
$5.82
Volume 24 ore:
1.55M
Relative Volume:
1.54
Capitalizzazione di mercato:
$331.22M
Reddito:
-
Utile/perdita netta:
$-44.80M
Rapporto P/E:
-7.3733
EPS:
-0.75
Flusso di cassa netto:
$-30.67M
1 W Prestazione:
-5.63%
1M Prestazione:
+8.86%
6M Prestazione:
-10.37%
1 anno Prestazione:
-12.50%
Intervallo 1D:
Value
$5.50
$5.88
Intervallo di 1 settimana:
Value
$5.50
$5.93
Portata 52W:
Value
$1.14
$7.20

Aldeyra Therapeutics Inc Stock (ALDX) Company Profile

Name
Nome
Aldeyra Therapeutics Inc
Name
Telefono
781-761-4904
Name
Indirizzo
131 HARTWELL AVENUE, LEXINGTON, MA
Name
Dipendente
8
Name
Cinguettio
@aldeyraaldx
Name
Prossima data di guadagno
2025-08-08
Name
Ultimi documenti SEC
Name
ALDX's Discussions on Twitter

Confronta ALDX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ALDX
Aldeyra Therapeutics Inc
5.53 345.26M 0 -44.80M -30.67M -0.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Aldeyra Therapeutics Inc Stock (ALDX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-04-03 Aggiornamento Oppenheimer Perform → Outperform
2024-04-02 Ripresa H.C. Wainwright Buy
2022-04-27 Ripresa H.C. Wainwright Buy
2021-02-08 Iniziato H.C. Wainwright Buy
2020-12-16 Iniziato Berenberg Buy
2020-10-30 Iniziato Jefferies Buy
2020-10-16 Iniziato BTIG Research Buy
2020-09-22 Iniziato Alliance Global Partners Buy
2020-05-12 Iniziato Oppenheimer Outperform
2018-12-04 Iniziato Citigroup Buy
2018-09-26 Reiterato Cantor Fitzgerald Overweight
2018-09-13 Iniziato Janney Buy
2018-01-26 Iniziato Seaport Global Securities Buy
2016-09-26 Iniziato H.C. Wainwright Buy
2016-07-01 Iniziato Stifel Buy
2015-07-01 Iniziato Canaccord Genuity Buy
2015-03-25 Iniziato Chardan Capital Markets Buy
2015-03-20 Reiterato H.C. Wainwright Buy
2014-11-18 Iniziato H.C. Wainwright Buy
2014-06-19 Iniziato Aegis Capital Buy
Mostra tutto

Aldeyra Therapeutics Inc Borsa (ALDX) Ultime notizie

pulisher
Sep 03, 2025

Can Aldeyra Therapeutics Inc. generate free cash flowJuly 2025 Levels & Consistent Growth Stock Picks - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Historical volatility pattern of Aldeyra Therapeutics Inc. visualized2025 Momentum Check & Risk Controlled Stock Pick Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using fundamentals and technicals on Aldeyra Therapeutics Inc.Portfolio Performance Summary & Long-Term Capital Growth Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Aldeyra Therapeutics Inc. a candidate for recovery playQuarterly Portfolio Report & Smart Swing Trading Techniques - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Advanced analytics toolkit walkthrough for Aldeyra Therapeutics Inc.Weekly Gains Report & Daily Oversold Bounce Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Sector ETF performance correlation with Aldeyra Therapeutics Inc.Portfolio Gains Report & Daily Technical Stock Forecast Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What technical models suggest about Aldeyra Therapeutics Inc.’s comeback2025 Short Interest & Reliable Price Action Trade Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Aldeyra Therapeutics: A High-Potential Biotech Play in Immune-Mediated and Ophthalmic Diseases - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Will Aldeyra Therapeutics Inc. outperform the marketMarket Rally & Weekly High Return Opportunities - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Tech Rally: Is Aldeyra Therapeutics Inc. stock forming a cup and handleTrade Risk Summary & High Return Stock Watch Alerts - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Aldeyra Therapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - Business Wire

Sep 03, 2025
pulisher
Sep 03, 2025

Comparing Aldeyra Therapeutics Inc. in custom built stock radarsQuarterly Profit Summary & Long-Term Safe Investment Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Real time scanner hits for Aldeyra Therapeutics Inc. explainedBreakout Watch & Daily Stock Trend Watchlist - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Ranking Aldeyra Therapeutics Inc. among high performing stocks via tools2025 Price Momentum & Risk Managed Trade Strategies - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

News impact scoring models applied to Aldeyra Therapeutics Inc.July 2025 Trade Ideas & Daily Market Momentum Tracking - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Market reaction to Aldeyra Therapeutics Inc.’s recent newsMarket Performance Report & Daily Entry Point Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can trapped investors hope for a rebound in Aldeyra Therapeutics Inc.Portfolio Update Report & Risk Controlled Swing Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Full technical analysis of Aldeyra Therapeutics Inc. stockJuly 2025 Summary & Safe Capital Preservation Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How to integrate Aldeyra Therapeutics Inc. into portfolio analysis toolsPortfolio Value Summary & Expert Verified Movement Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Earnings visualization tools for Aldeyra Therapeutics Inc.Market Performance Report & Long-Term Capital Growth Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What dividend growth rate does Aldeyra Therapeutics Inc. offer2025 Investor Takeaways & Technical Pattern Alert System - khodrobank.com

Sep 03, 2025
pulisher
Sep 02, 2025

Is Aldeyra Therapeutics Inc. stock forming a cup and handle2025 Biggest Moves & Risk Managed Investment Strategies - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Is Aldeyra Therapeutics Inc. trending in predictive chart modelsWeekly Trade Summary & Real-Time Sentiment Analysis - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

How moving averages guide Aldeyra Therapeutics Inc. trading2025 Market WrapUp & Risk Controlled Daily Plans - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

How to manage a losing position in Aldeyra Therapeutics Inc.Forecast Cut & Low Drawdown Momentum Trade Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Backtesting results for Aldeyra Therapeutics Inc. trading strategiesIndex Update & Low Drawdown Trading Techniques - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

How to escape a deep drawdown in Aldeyra Therapeutics Inc.July 2025 Reactions & Verified Swing Trading Watchlist - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Can machine learning forecast Aldeyra Therapeutics Inc. recoveryMarket Risk Analysis & Fast Moving Trade Plans - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Aldeyra Therapeutics Inc. benefiting from interest rate changesJuly 2025 Snapshot & Verified Swing Trading Watchlist - khodrobank.com

Sep 02, 2025
pulisher
Sep 01, 2025

Can Aldeyra Therapeutics Inc. expand its profit marginsWeekly Risk Report & Precise Entry and Exit Recommendations - خودرو بانک

Sep 01, 2025
pulisher
Aug 31, 2025

Is Aldeyra Therapeutics Inc. stock bottoming outTrade Risk Assessment & Low Risk High Reward Ideas - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Heatmap analysis for Aldeyra Therapeutics Inc. and competitorsStock Surge & Risk Adjusted Buy/Sell Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Aldeyra Therapeutics Inc. stock trendline breakdown2025 Key Highlights & Risk Controlled Stock Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Detecting support and resistance levels for Aldeyra Therapeutics Inc.July 2025 Closing Moves & Short-Term Trading Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Will Aldeyra Therapeutics Inc. rebound enough to break evenWeekly Stock Recap & Weekly Breakout Watchlists - Newser

Aug 31, 2025

Aldeyra Therapeutics Inc Azioni (ALDX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Aldeyra Therapeutics Inc Azioni (ALDX) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Machatha Stephen
Chief Development Officer
Aug 11 '25
Sale
5.15
22,073
113,713
221,799
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Capitalizzazione:     |  Volume (24 ore):